Search
Descriptor English: Iodipamide
Descriptor Spanish: Yodipamida
Descriptor yodipamida
Entry term(s) adipiodona
Scope note: Medio de contraste radiográfico hidrosoluble para la realización de colecistografías y colangiografías intravenosas.
Descriptor Portuguese: Iodopamida
Descriptor French: Adipiodone
Entry term(s): Adipiodon
Bilignost
Biligrafine
Bilipolinum
Cholografin
Endocistobil
Endographin
Tree number(s): D02.241.223.100.400.880.380
D02.455.426.559.389.127.375.880.380
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D007458
Scope note: A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AN analysis
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
Pharm Action: Contrast Media
Registry Number: TKQ858A3VW
CAS Type 1 Name: Benzoic acid, 3,3'-((1,6-dioxo-1,6-hexanediyl)diimino)bis(2,4,6-triiodo)-
DeCS ID: 7622
Unique ID: D007458
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2013/07/08
Iodipamide - Preferred
Concept UI M0011648
Scope note A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.
Preferred term Iodipamide
Entry term(s) Adipiodon
Biligrafine - Narrower
Concept UI M0011644
Preferred term Biligrafine
Bilipolinum - Narrower
Concept UI M0011645
Preferred term Bilipolinum
Endocistobil - Narrower
Concept UI M0011646
Preferred term Endocistobil
Endographin - Narrower
Concept UI M0011647
Preferred term Endographin
Bilignost - Narrower
Concept UI M0011643
Preferred term Bilignost
Cholografin - Narrower
Concept UI M0351685
Preferred term Cholografin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey